Skip to content
Friday, January 27, 2023
Latest:
  • Enerkon Solar International (ENKS) Names New Board and Scientific Committee Members and Announces New FARA Filing in Support of Commercial Aspirations
  • European Commission Approves mAbxience’s Bevacizumab For The Treatment Of Certain Types Of Cancer
  • Biorem Reports $2.1 million Earnings for Fiscal 2020
  • Water Crisis Highlights Need for New Solutions & Technologies to Drive Conservation in Asian Agriculture
  • Identification and Management of Osteoporotic Fractures is Lacking, Putting Long-Term Health of Patients at Risk
Biotech Stock Trends

Biotech Stock Trends

Know First, Act First

  • New Drugs
  • General
  • Stock Market
  • Finance
  • Trending
  • International

New Drugs

BIOTCHNO New Drugs 

MindMed Signs Partnership with Swiss Psychedelic Drug Discovery Startup MindShift Compounds AG, Expands Development Pipeline and IP Portfolio with Next-Gen Psychedelic and Empathogenic Compounds

February 11, 2021April 8, 2021 Bachittar

  Canada NewsWire ZUG,Switzerland,Feb. 11, 2021/CNW/ — MindMed (NEO: MMED) (OTCQB: MMEDF) (DE: MMQ), a leading psychedelic medicine biotech company announced

Read more
BIOTCHNO New Drugs 

PAOG Takes Major CBD Pharmaceutical Development Step Forward

January 5, 2021May 24, 2021 vanessa

PAOG Takes Major CBD Pharmaceutical Development Step Forward  Sandusky, Ohio–(Newsfile Corp. – January 5, 2021) – PAO Group, Inc. (OTC

Read more
BIOTCHNO New Drugs 

LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Combination Demonstrated Statistically Significant Improvement in OS, PFS and ORR

December 17, 2020April 8, 2021 vanessa

LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Combination Demonstrated Statistically Significant Improvement in OS, PFS and ORR TOKYO, Dec 17, 2020 –

Read more
BIOTCHNO New Drugs 

Eisai: Biogen Files New Drug Application for Aducanumab in Japan

December 11, 2020April 8, 2021 vanessa

Eisai: Biogen Files New Drug Application for Aducanumab in Japan TOKYO, Dec 11, 2020 – (JCN Newswire) – Biogen and

Read more
BIOTCHNO New Drugs 

Eisai and Wren Therapeutics Enter Into Research Collaboration Agreement for Drug Discovery for Synucleinopathies

November 30, 2020April 8, 2021 vanessa

Eisai and Wren Therapeutics Enter Into Research Collaboration Agreement for Drug Discovery for Synucleinopathies TOKYO, Nov 30, 2020 – (JCN

Read more
BIOTCHNO New Drugs 

NewCentre for Medicines Research (CMR) Clinical Factbook From Clarivate Highlights Increasing Cost and Complexity of Phase II Trials

November 24, 2020April 15, 2021 vanessa

 Canada NewsWire LONDON, Nov. 24, 2020 Pharmaceutical clinical industry report highlights factors impacting volume, cost and duration of Phase II

Read more

Stock Market

AmpliTech Announces Closing of Upsized $9.6 Million Public Offering
BIOTCHNO Stock Market 

AmpliTech Announces Closing of Upsized $9.6 Million Public Offering

February 19, 2021April 8, 2021 Bachittar

Bohemia, New York–(Newsfile Corp. – February 19, 2021) – AmpliTech Group, Inc. (NASDAQ: AMPG) (NASDAQ: AMPGW) (the “Company”), a designer,

ESSA Pharma Announces Pricing of Public Offering of Common Shares
BIOTCHNO Stock Market 

ESSA Pharma Announces Pricing of Public Offering of Common Shares

February 17, 2021April 8, 2021 Bachittar
BioVaxys Announces Broadening Of Share Liquidity With DTCC Full Service Eligibility
BIOTCHNO Stock Market 

BioVaxys Announces Broadening Of Share Liquidity With DTCC Full Service Eligibility

February 16, 2021April 8, 2021 Bachittar
Proposed Disposition of Common Shares and Exercise of Warrants of SQI Diagnostics Inc.
BIOTCHNO Stock Market 

Proposed Disposition of Common Shares and Exercise of Warrants of SQI Diagnostics Inc.

February 10, 2021April 8, 2021 Bachittar
  • Disclaimer
  • Privacy Policy
TD Media LLC dba Life Water Media
1415 South Voss Road Suite 110-431 Houston, TX 77057